Costco (NASDAQ:COST) has faced a challenging 2025, marking one of its worst relative performances in over two decades.
J.P. Morgan Asset Management has launched its first tokenized money market fund, My OnChain Net Yield Fund (MONY), which is now available on the public Ethereum blockchain.
Does Installed Building Products (IBP) have what it takes to be a top stock pick for momentum investors? Let's find out.
COPT Defense (CDP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Daktronics (DAKT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Does The Bank of New York Mellon Corporation (BK) have what it takes to be a top stock pick for momentum investors? Let's find out.
Nuvation Bio (NUVB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Does Bread Financial Holdings (BFH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Seagate (STX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Does MongoDB (MDB) have what it takes to be a top stock pick for momentum investors? Let's find out.
Werewolf Therapeutics (HOWL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Does Prenetics Global Limited (PRE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Alto Ingredients (ALTO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Does O-I Glass (OI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Intensity Therapeutics Inc. (INTS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Does Northrim BanCorp (NRIM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Does Millicom International Cellular SA (TIGO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Does Vince Holding Corp. (VNCE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Does ADC Therapeutics SA (ADCT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Progyny (PGNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Bank7 (BSVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
REITs endured a brutal three-plus-year stretch since March 2022, underperforming the S&P 500 by an unprecedented 70 percentage points, far worse than the Global Financial Crisis. Extreme underperformance has left REITs historically cheap despite solid property-level fundamentals, but this valuation discount carries a cost: elevated capital costs, suppressed transaction activity, and limited external growth opportunities. Depressed public-market valuations have triggered a pronounced “REIT exodus,” with 40 REITs acquired, liquidated, or seeking sales since 2022, while new REIT formation has collapsed to a fraction of norms.
Select Water Solutions, Inc. (WTTR) Discusses Transition to Water Infrastructure Focus and Market Positioning Transcript
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Analyst/Investor Day Transcript
Cypherpunk Technologies Inc. (CYPH) Leap Therapeutics, Inc. - Shareholder/Analyst Call Prepared Remarks Transcript
Google appears to be running tests on putting real estate sale listings into its search results. The listings allowed users to view the full details of a property's page, request a tour and contact an agent — similar to the functions offered on Zillow.com's online marketplace portal.
Artificial intelligence is entering a new phase of infrastructure expansion, and one of the most important technologies enabling that growth is photonics. As AI models scale, the limiting factor is no longer pure compute, but the movement of data itself.
MHP SE (MHPSY) Q3 2025 Earnings Call Transcript
I'm downgrading Micron Technology, Inc. to a Hold ahead of its fiscal Q1 '26 release, despite strong AI-driven fundamentals and a 186.5% YTD rally. MU's pivot from consumer to enterprise DRAM/HBM, driven by AI and data center demand, supports a structurally bullish long-term thesis. DRAM and NAND pricing is surging amid supply constraints, but MU's near-term risk-reward is unfavorable given high expectations and recent sector volatility.